Luma Therapeutics

📍 Millbrae, United States👥 7 employees💰 Last funded 2016
Medical Devices🌐 illuvinate.com
Website LinkedIn
Headquartered in Millbrae, California, Luma Therapeutics is a medical device company founded with a vision to end the suffering of people with inflammatory skin conditions, starting with psoriasis. In the United States alone there are 7.5 million people suffering from psoriasis and it affects 120 million people worldwide. Evan Anderson, our Founder and CEO, is a psoriasis patient. After trying multiple existing options for treating his own psoriasis, Evan began tinkering with coal tar, occlusive dressings and light therapy inspired by the incredible clinical results of the Goeckerman regimen. The result is Luma's first product, illuvinate. illuvinate is Luma's recently launched treatment for psoriasis. It is an FDA-cleared, home-use product and is now available in Northern California. Results are seen in as little as 6 weeks.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Luma Therapeutics?
Luma Therapeutics has 1 investors on record on gritt.io.
When did Luma Therapeutics last raise funding?
The most recent investment in Luma Therapeutics recorded on gritt.io was in 2016.
What industry is Luma Therapeutics in?
Luma Therapeutics operates in Medical Devices. Find similar Medical Devices investors on gritt.io.
Where is Luma Therapeutics based?
Luma Therapeutics is headquartered in Millbrae, United States.